Multiple Myeloma

Spectrum says U.S. FDA declines to approve Evomela for injection
Yahoo/Reuters
Sat, 10/24/15 - 03:37 pm
FDA
Spectrum Pharmaceuticals
Evomela
Multiple Myeloma
FDA Grants Priority Review for Amgen's Supplemental New Drug Application for Expanded Labeling of Kyprolis® (Carfilzomib) in Relapsed Multiple Myeloma
Yahoo
Fri, 09/18/15 - 09:17 pm
FDA
Kyprolis
Amgen
Multiple Myeloma
Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?
TheStreet.com
Tue, 09/1/15 - 06:46 pm
Bristol-Myers Squibb
priority review
FDA
Multiple Myeloma
Empliciti
Bristol-Myers and AbbVie speed toward FDA approval with a 'breakthrough' cancer drug
Fierce Biotech
Tue, 09/1/15 - 06:38 pm
AbbVie
Bristol-Myers Squibb
FDA
elotuzumab
Multiple Myeloma
J&J positions blockbuster contender daratumumab for a multiple myeloma showdown
Fierce Biotech
Thu, 08/27/15 - 09:55 am
JNJ
daratumumab
Multiple Myeloma
Kyprolis
Amgen
Genmab
elotuzumab
AbbVie
Bristol-Myers Squibb
Amgen wins new myeloma nod for blockbuster hopeful Kyprolis
Fierce Pharma
Mon, 07/27/15 - 01:46 pm
Amgen
Multiple Myeloma
Kyprolis
Celgene
Pomolyst
Amgen awaiting FDA decision on cancer drug Kyprolis
BioPharma Dive
Tue, 07/14/15 - 11:44 am
Amgen
FDA
Kyprolis
Multiple Myeloma
Amgen's Single Most Important FDA Decision of 2015 Is Nearly Here
Motley Fool
Thu, 07/9/15 - 07:46 pm
Amgen
FDA
Multiple Myeloma
Kyprolis
Novartis scores recommendation from EMA for myeloma drug Farydak
Fierce Pharma
Fri, 06/26/15 - 11:51 am
Novartis
Farydak
Multiple Myeloma
Europe
Is This Johnson & Johnson's Next Blockbuster?
Investopedia
Wed, 06/10/15 - 09:50 pm
JNJ
Multiple Myeloma
daratumumab
Genmab shares rise on cancer drug's FDA license application
Yahoo/Reuters
Mon, 06/8/15 - 10:07 am
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
J&J multiple myeloma drug offers hope after others stop working -study
Yahoo/Reuters
Sat, 05/30/15 - 11:55 am
JNJ
Multiple Myeloma
ASCO
daratumumab
Bristol, AbbVie drug extends multiple myeloma remission-study
Yahoo/Reuters
Thu, 05/14/15 - 09:56 am
Bristol-Myers Squibb
AbbVie
Multiple Myeloma
elotuzumab
Amgen Hopes Kyprolis Can Become a Blockbuster
Investopedia
Thu, 04/2/15 - 11:31 am
Amgen
Kyprolis
Multiple Myeloma
MorphoSys tanks after Celgene walks away from $818M pact
Fierce Biotech
Fri, 03/27/15 - 10:13 am
MorphoSys
Celgene
Multiple Myeloma
Was Onyx worth it? Amgen's case is looking up as Kyprolis bests Velcade in head-to-head trial
Fierce Pharma
Tue, 03/3/15 - 08:05 am
ONYX Pharmaceuticals
Amgen
Velcade
Kyprolis
Multiple Myeloma
Amgen's Kyprolis Outperforms Rival Drug In Study
Forbes
Mon, 03/2/15 - 08:05 am
Amgen
Kyprolis
Velcade
Takeda
Multiple Myeloma
Celgene's Approval Means That Sales Could Surge
Investopedia
Fri, 02/27/15 - 10:05 am
Celgene
Multiple Myeloma
Revlimid
FDA approves Novartis's multiple myeloma drug Farydak
Pharmaceutical Business Review
Wed, 02/25/15 - 10:01 am
Novartis
Farydak
Multiple Myeloma
FDA approves Novartis drug for bone marrow cancer
Yahoo/AP
Mon, 02/23/15 - 09:14 pm
FDA
Novartis
Multiple Myeloma
Farydak

Pages